Premium
The high incidence of severe chronic kidney disease after intestinal transplantation and its impact on patient and graft survival
Author(s) -
Huard Geneviève,
Iyer Kishore,
Moon Jang,
Doucette John T.,
Nair Vinay,
Schiano Thomas D.
Publication year - 2017
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.12942
Subject(s) - medicine , incidence (geometry) , transplantation , kidney transplantation , kidney disease , surgery , disease , physics , optics
Using data from the Scientific Registry of Transplant Recipients ( SRTR ), cumulative incidence, risk factors for, and impact on survival of severe chronic kidney disease ( CKD ) in intestinal transplantation ( IT x) recipients were assessed. Methods First‐time adult IT x recipients transplanted in the United States between January 1, 1990 and December 31, 2012 were included. Severe CKD after IT x was defined as: glomerular filtration rate ( GFR ) <30 mL/min/1.73 m 2 , chronic hemodialysis initiation, or kidney transplantation ( KT x). Survival analysis and extended Cox model were conducted. Results The cumulative incidence of severe CKD 1, 5, and 10 years after IT x was 3.2%, 25.1%, and 54.1%, respectively. The following characteristics were significantly associated with severe CKD : female gender ( HR 1.34), older age ( HR 1.38/10 year increment), catheter‐related sepsis ( HR 1.58), steroid maintenance immunosuppression ( HR 1.50), graft failure ( HR 1.76), ACR ( HR 1.64), prolonged requirement for IV fluids ( HR 2.12) or TPN ( HR 1.94), and diabetes ( HR 1.54). Individuals with higher GFR at the time of IT x ( HR 0.92 for each 10 mL/min/1.73 m 2 increment), and those receiving induction therapies ( HR 0.47) or tacrolimus ( HR 0.52) showed lower hazards of severe CKD . In adjusted analysis, severe CKD was associated with a significantly higher hazard of death ( HR 6.20). Conclusions The incidence of CKD after IT x is extremely high and its development drastically limits post‐transplant survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom